A proposed model for conducting institutional-specific cost-effectiveness analysis: a case study of lipid-lowering agents.
Hakim
Z
Z
Roche Bioscience, Palo Alto, CA, USA.
Pierson
J F
JF
Pathak
D S
DS
D003362:Cost-Benefit Analysis / Q000379:methods*; D017850:Economics, Pharmaceutical; D015276:Health Care Rationing; D006302:Health Services Research / Q000191:economics / Q000379:methods*; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D017059:Models, Econometric; D010607:Pharmacy Service, Hospital / Q000191:economics*; D014481:United States